doi: 10.1136/bmj.302.6782.965
PMID: 1827745
- Down's syndrome screening: risk calculation software requirements Read the software requirements for risk calculation in Down's syndrome screening, as part of the NHS fetal anomaly screening.
- Impact of a new national screening policy for Down’s syndrome in Denmark: population based cohort study. Charlotte K Ekelund. Down’s syndrome was diagnosed prenatally by an invasive procedure carried out for indications other than an increased risk of Down’s syndrome.
Testing for Downs Syndrome. – indirect fetal testing, by biochemical maternal serum screening, was introduced – maternal serum screening does not detect specific marker – multiple biochemical markers used to calculate risk – software packages available to calculate risk – can screen in first or second trimester.
See letter 'Biochemical screening for Down's syndrome.' on page 1275.
This article has been cited by other articles in PMC.
Full text
Beard Preventing Brand
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (302K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Down Syndrome Screening Risk Calculation Software Free
These references are in PubMed. This may not be the complete list of references from this article.
- Chamberlain G. ABC of antenatal care. Normal antenatal management. BMJ. 1991 Mar 30;302(6779):774–779.[PMC free article] [PubMed] [Google Scholar]
- Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA. Maternal serum screening for Down's syndrome in early pregnancy. BMJ. 1988 Oct 8;297(6653):883–887.[PMC free article] [PubMed] [Google Scholar]
- Macri JN, Kasturi RV, Krantz DA, Cook EJ, Sunderji SG, Larsen JW. Maternal serum Down syndrome screening: unconjugated estriol is not useful. Am J Obstet Gynecol. 1990 Mar;162(3):672–673. [PubMed] [Google Scholar]
- Bartels I, Lindemann A. Maternal levels of pregnancy-specific beta 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome. Hum Genet. 1988 Sep;80(1):46–48. [PubMed] [Google Scholar]
- O'Brien WF, Knuppel RA, Torres C, Sternlicht D. Potential prenatal predictions of Down syndrome: a statistical analysis. Am J Obstet Gynecol. 1990 Dec;163(6 Pt 1):1796–1798. [PubMed] [Google Scholar]
- Cuckle HS, Wald NJ, Goodburn SF, Sneddon J, Amess JA, Dunn SC. Measurement of activity of urea resistant neutrophil alkaline phosphatase as an antenatal screening test for Down's syndrome. BMJ. 1990 Nov 3;301(6759):1024–1026.[PMC free article] [PubMed] [Google Scholar]
Associated Data
- Supplementary Materials
Articles from The BMJ are provided here courtesy of BMJ Publishing Group